OA11956A - Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions. - Google Patents

Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions. Download PDF

Info

Publication number
OA11956A
OA11956A OA1200100318A OA1200100318A OA11956A OA 11956 A OA11956 A OA 11956A OA 1200100318 A OA1200100318 A OA 1200100318A OA 1200100318 A OA1200100318 A OA 1200100318A OA 11956 A OA11956 A OA 11956A
Authority
OA
OAPI
Prior art keywords
citrate monohydrate
citrate
crystalline
hours
octan
Prior art date
Application number
OA1200100318A
Other languages
English (en)
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA11956A publication Critical patent/OA11956A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA1200100318A 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions. OA11956A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
OA11956A true OA11956A (en) 2006-04-13

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200100318A OA11956A (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions.

Country Status (49)

Country Link
US (1) US6255320B1 (fr)
EP (1) EP1181290B1 (fr)
JP (1) JP3830816B2 (fr)
KR (1) KR100476606B1 (fr)
CN (1) CN1146565C (fr)
AP (1) AP2001002349A0 (fr)
AR (1) AR033331A1 (fr)
AT (1) ATE244239T1 (fr)
AU (1) AU767334B2 (fr)
BG (1) BG65240B1 (fr)
BR (1) BR0011094A (fr)
CA (1) CA2372238C (fr)
CO (1) CO5170463A1 (fr)
CY (1) CY2007011I2 (fr)
CZ (1) CZ295819B6 (fr)
DE (1) DE60003679T2 (fr)
DK (1) DK1181290T3 (fr)
DZ (1) DZ3050A1 (fr)
EA (1) EA003731B1 (fr)
EC (1) ECSP003508A (fr)
EE (1) EE200100656A (fr)
ES (1) ES2199825T3 (fr)
GT (1) GT200000087A (fr)
HK (1) HK1046284A1 (fr)
HN (1) HN2000000077A (fr)
HR (1) HRP20010904A2 (fr)
HU (1) HUP0201301A3 (fr)
IL (1) IL146406A0 (fr)
MA (1) MA26742A1 (fr)
MX (1) MXPA01012325A (fr)
MY (1) MY133508A (fr)
NO (1) NO20015848L (fr)
NZ (1) NZ515349A (fr)
OA (1) OA11956A (fr)
PA (1) PA8496101A1 (fr)
PE (1) PE20010209A1 (fr)
PL (1) PL196046B1 (fr)
PT (1) PT1181290E (fr)
SI (1) SI1181290T1 (fr)
SK (1) SK285820B6 (fr)
SV (1) SV2001000093A (fr)
TN (1) TNSN00120A1 (fr)
TR (1) TR200103473T2 (fr)
TW (1) TWI285204B (fr)
UA (1) UA66925C2 (fr)
UY (1) UY26176A1 (fr)
WO (1) WO2000073304A1 (fr)
YU (1) YU81101A (fr)
ZA (1) ZA200109775B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06008648A (es) * 2004-01-30 2006-09-04 Pfizer Prod Inc Composiciones farmaceuticas de antagonistas del receptor de neuroquinina y ciclodextrina y metodos para una tolerancia mejorada en el sitio de inyeccion.
WO2005082416A2 (fr) * 2004-01-30 2005-09-09 Pfizer Products Inc. Conservateurs antimicrobiens permettant l'obtention d'une formulation multi-dose au moyen de beta-cyclodextrines pour des formes posologiques liquides
JP2007519701A (ja) * 2004-01-30 2007-07-19 ファイザー・プロダクツ・インク 麻酔回復を改善するためのｎｋ−１受容体拮抗剤
JP2007519710A (ja) * 2004-02-02 2007-07-19 ファイザー・プロダクツ・インク １−（２Ｓ，３Ｓ）−２−ベンズヒドリル−Ｎ−（５−ｔｅｒｔ−ブチル−２−メトキシベンジル）キヌクリジン−３−アミンの製造方法
KR102391332B1 (ko) * 2013-03-15 2022-04-26 펄 테라퓨틱스 인코포레이티드 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69208877T2 (de) * 1991-05-31 1996-07-25 Pfizer Chinuclidinderivate
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
CY2007011I1 (el) 2010-07-28
HRP20010904A2 (en) 2003-02-28
TR200103473T2 (tr) 2002-04-22
SK285820B6 (sk) 2007-09-06
EE200100656A (et) 2003-02-17
YU81101A (sh) 2004-07-15
ECSP003508A (es) 2002-02-25
IL146406A0 (en) 2002-07-25
CN1353711A (zh) 2002-06-12
CZ295819B6 (cs) 2005-11-16
BG106204A (en) 2002-07-31
PE20010209A1 (es) 2001-03-01
HK1046284A1 (en) 2003-01-03
MXPA01012325A (es) 2002-07-22
CZ20014269A3 (cs) 2002-04-17
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
HUP0201301A3 (en) 2002-10-28
EP1181290B1 (fr) 2003-07-02
PT1181290E (pt) 2003-09-30
UA66925C2 (uk) 2004-06-15
NZ515349A (en) 2004-03-26
EA003731B1 (ru) 2003-08-28
KR20020010688A (ko) 2002-02-04
UY26176A1 (es) 2000-12-29
CA2372238C (fr) 2006-12-19
NO20015848D0 (no) 2001-11-30
KR100476606B1 (ko) 2005-03-18
SI1181290T1 (en) 2003-12-31
AR033331A1 (es) 2003-12-17
TNSN00120A1 (fr) 2005-11-10
DE60003679D1 (de) 2003-08-07
DK1181290T3 (da) 2003-09-29
MA26742A1 (fr) 2004-12-20
PL352716A1 (en) 2003-09-08
CN1146565C (zh) 2004-04-21
JP3830816B2 (ja) 2006-10-11
MY133508A (en) 2007-11-30
AU767334B2 (en) 2003-11-06
CO5170463A1 (es) 2002-06-27
ZA200109775B (en) 2002-11-28
EP1181290A1 (fr) 2002-02-27
ES2199825T3 (es) 2004-03-01
SK17332001A3 (sk) 2002-07-02
BG65240B1 (bg) 2007-09-28
GT200000087A (es) 2001-11-22
TWI285204B (en) 2007-08-11
BR0011094A (pt) 2002-03-19
EA200101108A1 (ru) 2002-04-25
AU4424800A (en) 2000-12-18
CY2007011I2 (el) 2010-07-28
JP2003501354A (ja) 2003-01-14
PL196046B1 (pl) 2007-11-30
SV2001000093A (es) 2001-11-08
HUP0201301A2 (en) 2002-08-28
PA8496101A1 (es) 2002-07-30
DE60003679T2 (de) 2004-05-27
WO2000073304A1 (fr) 2000-12-07
HN2000000077A (es) 2001-02-02
DZ3050A1 (fr) 2004-03-27
ATE244239T1 (de) 2003-07-15
CA2372238A1 (fr) 2000-12-07
AP2001002349A0 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
US6939856B2 (en) Method for preparing dexchlor tannate
OA11956A (en) Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions.
US6262067B1 (en) Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
EP0009608B1 (fr) Dérivés de N-phénéthyl-acétamide, procédés pour leur préparation et compositions thérapeutiques les contenant
US6387925B1 (en) Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions
EP0703915B1 (fr) Xamoneline tartrate
US7001886B2 (en) Hot melt method for preparing diphenhydramine tannate
US4420488A (en) Quaternary 1,1-diphenyl-4-pyrrolidinium-2-butyne salts, a process for their production and medicaments containing these compounds
WO1999055662A1 (fr) Mesylate de tilidine, procedes de preparation associes et composition pharmaceutique le contenant